Home › Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses
 

Keywords :   


Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses

2014-11-15 12:08:06| Biotech - Topix.net

The National Institutes of Health awarded Integral Molecular Inc. a five-year, $3.5 million contract to study the human immune response to the Ebola virus and hepatitis C virus. The funding will enable the Philadelphia biotechnology company to better understand how human antibodies protect, or fail to protect, people against such viruses.

Tags: study firm contract philadelphia

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
15.05European Wax Center\'s EWC Treat Brightening Ingrown Hair Wipes Awarded
15.05Atlantic Tropical Weather Outlook
15.05PBE Makes Investment in Plus-Size Adult Incontinence Products
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
More »